drugset
Drugs / HTNV/PUUV DNA vaccine
last change Jul 2017 re-read 3 minutes ago

HTNV/PUUV DNA vaccine

Vaccine

Developed for
hantavirus hemorrhagic fever with renal syndrome
Investigated by
Ichor Medical Systems Incorporated · U.S. Army Medical Research and Development Command · US Army Medical Research Institute of Infectious Diseases · United States Army Medical Materiel Development Activity · Walter Reed Army Institute of Research (WRAIR)

Trials 1

today NCT02116205 · Ph 2
2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02116205 Jul 2014 → Dec 2016 hantavirus hemorrhagic fever with renal syndrome U.S. Army Medical Research and Development Command Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HTNV/PUUV DNA vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02116205 ↗
Modality Vaccine “HTNV/PUUV DNA vaccine mixture” NCT02116205 ↗
Route Intramuscular “1.0 mg HTNV/PUUV DNA vaccine IM-EP via TriGrid™ Delivery System (TDS)” NCT02116205 ↗